About Lonza Netherlands B.V.

- Company -

Lonza Netherlands, former PharmaCell was founded in 2005 as a Contract Manufacturing Organisation in Europe for Cell Therapy and Regenerative Medicine.

Lonza supports Phase I to Phase III clinical trials. Next to clinical trials manufacturing, Lonza also manufactures commercial cell therapy products for the European market.

Lonza’s international team consists of experts related to all quality aspects, manufacturing, engineering, process development and project management. Each department has a representative in a dedicated core team that is committed to your product manufacturing and becomes involved from the Technology Transfer onwards.

Lonza Netherlands and Lonza Geleen Cell Therapy CMO services range from thorough transfer of technologies, QP release of products for the EU market, controlled temperature transportation to process development, including cell culture scale-up know-how and manufacturing of Advanced Therapeutic Medicinal Products.

GMP Certification CMF Geleen

The Geleen Cell Manufacturing Facility was first GMP certified in 2012 by the Dutch authorities (IGZ).

Fact sheet

GMP Certification CMF Maastricht

Our Maastricht Cell Manufacturing Facility was first GMP certified in 2006 and has been successfully inspected by the Dutch Authorities (IGZ) on a regular basis thereafter.

Fact sheet